Spark Therapeutics: 3Q Earnings Snapshot
PHILADELPHIA (AP) _ Spark Therapeutics Inc. (ONCE) on Tuesday reported a loss of $47.4 million in its third quarter.
The Philadelphia-based company said it had a loss of $1.26 per share.
The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.04 per share.
The gene therapy developer posted revenue of $10.7 million in the period, also falling short of Street forecasts. Seven analysts surveyed by Zacks expected $26.1 million.
Spark Therapeutics shares have dropped 14 percent since the beginning of the year. The stock has declined 46 percent in the last 12 months.